Dergiler / Turkish Journal of Medical Sciences / 2015 / Cilt: 45 - Sayı: 2

Hemodynamic effects of atrial natriuretic peptide in ischemia-reperfusion injury that occurs after exercise

Sayfa
298–305
Yayın Tarihi
2015-08-13
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: This study indicated that higher ANP concentrations before ischemia were more effective on the left ventricle contractility and relaxation functions in the hearts that were exposed to exercise.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Atrial natriuretic peptide (ANP) is known as a protective agent against ischemia-reperfusion injury for cardiomyocytes.
📊
Temel Bulgular & Veri:Materials and methods: Isolated hearts were perfused in 4 exercised (E) groups after a running protocol for 5 days and 4 nonexercised (NE) groups.
💡
Sonuç & Katkı:Conclusion: This study indicated that higher ANP concentrations before ischemia were more effective on the left ventricle contractility and relaxation functions in the hearts that were exposed to exercise.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Atrial natriuretic peptide · ischemia · exercise

Özet

Atrial natriuretic peptide (ANP) is known as a protective agent against ischemia-reperfusion injury for cardiomyocytes. We compared the hemodynamic effects of ANP and isatin, which is known as an ANP receptor blocker, in ischemia followed by reperfusion in exercised rat hearts with nonexercised ones. Materials and methods: Isolated hearts were perfused in 4 exercised (E) groups after a running protocol for 5 days and 4 nonexercised (NE) groups. In the first protocol, ANP was added to the perfusion solution before ischemia in an E and NE group. In the second protocol, different doses of isatin (0.1, 10, 100 µM/L) were added to the perfusion solution before ANP in 3 E and 3 NE groups. Left ventricular developed pressure (LVDP) and maximum and minimum rates of change in left ventricular pressure (dP/dtmax and dP/dtmin) were recorded. Results: Higher LVDP and dP/dtmin values were observed in the E group than the NE group following addition of ANP before ischemia. Values of dP/dtmax were higher in the E group at the first minute of reperfusion period. Hemodynamic difference was not observed between groups given the same amount of isatin before ANP. Conclusion: This study indicated that higher ANP concentrations before ischemia were more effective on the left ventricle contractility and relaxation functions in the hearts that were exposed to exercise.

Abstract

Atrial natriuretic peptide (ANP) is known as a protective agent against ischemia-reperfusion injury for cardiomyocytes. We compared the hemodynamic effects of ANP and isatin, which is known as an ANP receptor blocker, in ischemia followed by reperfusion in exercised rat hearts with nonexercised ones. Materials and methods: Isolated hearts were perfused in 4 exercised (E) groups after a running protocol for 5 days and 4 nonexercised (NE) groups. In the first protocol, ANP was added to the perfusion solution before ischemia in an E and NE group. In the second protocol, different doses of isatin (0.1, 10, 100 µM/L) were added to the perfusion solution before ANP in 3 E and 3 NE groups. Left ventricular developed pressure (LVDP) and maximum and minimum rates of change in left ventricular pressure (dP/dtmax and dP/dtmin) were recorded. Results: Higher LVDP and dP/dtmin values were observed in the E group than the NE group following addition of ANP before ischemia. Values of dP/dtmax were higher in the E group at the first minute of reperfusion period. Hemodynamic difference was not observed between groups given the same amount of isatin before ANP. Conclusion: This study indicated that higher ANP concentrations before ischemia were more effective on the left ventricle contractility and relaxation functions in the hearts that were exposed to exercise.

🔖

Bu Makaleye Atıf Yap

VARDAR, S. A., PALABIYIK, O., TOPUZ, R. D., GÜREL, E. E., ÇALIŞKAN, S., ÖZEN, S. T., SÜT, N., KARADAĞ, Ç. H. (2015). Hemodynamic effects of atrial natriuretic peptide in ischemia-reperfusion injury that occurs after exercise. Turkish Journal of Medical Sciences, Cilt: 45 - Sayı: 2, 298–305. https://ajindex.com/articles/114030

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Clerico A. Vittorini S. The cardiac natriuretic hormone system. In: Clerico A, Emdin M, editors. Natriuretic Peptides: The Hormones of the Heart. Trento, Italy: Springer-Verlag Italia; 2006. pp. 21–64
  2. Raine AE, Erne P, Bürgisser E, Müller FB, Bolli P, Burkart F, Bühler FR. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 1986; 315: 533–537
  3. Karakuşoğlu Ö, Vardar SA, Kunduracılar H, Süt N. Effects of short duration supramaximal exercise on plasma atrial natriuretic peptide concentrations in healthy subjects. Turkiye Klinikleri J Sports Sci 2010; 2: 1–6
  4. Mandroukas K, Zakas A, Aggelopoulou N, Christoulas K, Abatzides G, Karamouzis M. Atrial natriuretic factor responses to submaximal and maximal exercise. Br J Sports Med 1995; 29: 248–251
  5. Onuoha GN, Nicholls DP, Patterson A, Beringer T. Neuropeptide secretion in exercise. Neuropeptides 1998; 32: 319–325
  6. Gerczuk PZ, Kloner RA. An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J Am Coll Cardiol 2012; 59: 969–978
  7. Wakui S, Sezai A, Tenderich G, Hata M, Osaka S, Taniguchi Y, Koerfer R, Minami K. Experimental investigation of direct myocardial protective effect of atrial natriuretic peptide in cardiac surgery. J Thorac Cardiovasc Surg 2010; 139: 918–925
  8. Yang XM, Philipp S, Downey JM, Cohen MV. Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts. Basic Res Cardiol 2006; 101: 311–318
  9. Kasama S, Furuya M, Toyama T, Ichikawa S, Kurabayashi M. Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction. Eur Heart J 2008; 29: 1485–1494
  10. Sangawa K, Nakanishi K, Ishino K, Inoue M, Kawada M, Sano S. Atrial natriuretic peptide protects against ischemia-reperfusion injury in the isolated rat heart. Ann Thorac Surg 2004; 77: 233– 237
  11. Dickson EW, Hogrefe CP, Ludwig PS, Ackermann LW, Stoll LL, Denning GM. Exercise enhances myocardial ischemic tolerance via an opioid receptor-dependent mechanism. Am J Physiol Heart Circ Physiol 2008; 294: H402–408
  12. Opie LH. Ventricular function. In: Opie LH, editor. Heart Physiology from Cell to Circulation. 3rd ed. Philadelphia, PA, USA: Lippincott Williams & Wilkins; 1998. pp. 343–389
  13. Date H, Imamura T, Onitsuka H, Maeno M, Watanabe R, Nishihira K, Matsuo T, Eto T. Differential increase in natriuretic peptides i